Spevigo (spesolimab or spesolimab-sbzo) treats generalized pustular psoriasis (GPP) in people ages 12 years and older. This medication is a biologic that's called an interleukin antagonist. For GPP flares, Spevigo (spesolimab) is given as an infusion through the vein (IV) by a healthcare professional. Side effects include fatigue and nausea for the IV infusion. For continued treatment of GPP, you inject the medication under the skin every month using a prefilled syringe. Pain and swelling is possible where the medication is injected under the skin.
Generalized pustular psoriasis (GPP) in people ages 12 years and older who weigh at least 88 lbs
Spevigo (spesolimab) is a monoclonal antibody that works as an interleukin antagonist. It blocks a protein in your immune system that plays a role in inflammation called interleukin-36 from attaching to its receptor. This helps lower inflammation.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Can clear up pustules as early as a week after an IV dose for a GPP flare
Available as an under-the-skin injection to help prevent GPP flares
Can give under-the-skin injections for maintenance treatment at home
No known interactions with other medications
Must be given as an injection into the vein or under the skin
Must store in the refrigerator
Hasn't been studied in children younger than 12 years old
No lower-cost generic available; brand-name medication only
Mark your calendar with your appointments to see your prescriber. This is important especially if you're getting Spevigo (spesolimab) as an IV infusion so that you avoid missing your doses. Regular check-ins with your prescriber also gives you time to discuss with them about how well Spevigo (spesolimab) is working and any bothersome side effects you might have.
Spevigo (spesolimab) can raise your risk of getting a serious infection. Get medical help right away if you develop symptoms of an infection, such as fever, weakness, sweating, chills, cough, difficulty breathing, or diarrhea, while you're taking Spevigo (spesolimab). You might have to stop taking Spevigo (spesolimab) so your body can fight and fully recover from the infection.
Before you get any vaccines, tell your prescriber or pharmacist that you're taking Spevigo (spesolimab). They can make sure it's safe to get the vaccine you're interested in. You shouldn't get any live vaccines during and for at least 4 months after treatment, because it's not known if Spevigo (spesolimab) affects your immune system and raises your risk of infection from the vaccine.
Tips for IV infusions of Spevigo (spesolimab):
The IV infusion typically takes about 1.5 hours. But your care team might slow the infusion down and the infusion might take up to 3 hours if you have infusion-related reactions, such as weakness, nausea, vomiting, headache, or itchiness.
If you'd like, bring a book or other activity to the medical office to help pass the time.
Tips for under-the-skin injections of Spevigo (spesolimab):
After your first dose, your care team might let you inject Spevigo (spesolimab) at home. Carefully follow the instructions on how to inject Spevigo (spesolimab). You'll first get trained by a healthcare professional, but be sure to ask your care team if you have any questions about how to take the medication.
For each monthly dose of Spevigo (spesolimab), you'll need to use two prefilled syringes to inject the full dose of medication. Each prefilled syringe for the under-the-skin injections contains 150 mg of medication.
Keep Spevigo (spesolimab) prefilled syringes in the refrigerator and in the original carton to protect them from light. Before it's time for your dose, take the medication out of the refrigerator. Lay it on a flat surface for 15 to 30 minutes so it can reach room temperature. Don't try to warm up the medication any other way.
Inject Spevigo (spesolimab) under the skin into the fat tissue of your upper thighs or stomach area (at least 2 inches away from your belly button). Avoid injecting near your waistline or into skin that's tender, bruised, red, hard, or scarred. Don't inject into your muscle or vein; it's not meant to be injected this way.
To inject Spevigo (spesolimab), gently pinch the area of skin you're going to inject into with one hand. Then, use a dart-like motion to insert the needle of the prefilled syringe into the skin at a 45-degree angle with your other hand.
Choose a different area of skin to inject into each time; it should be at least an inch away from the previous area you injected into. You can alternate between the stomach area and thigh. This helps lower your risk for bruising and skin irritation.
After you inject the medication, throw away the used prefilled syringe in a sharps container or some heavy-duty plastic container, such as an empty milk carton or laundry detergent bottle. This helps lower the risk for needle-stick injuries. Don't throw away syringes in your trash can. Visit the FDA's website for guidance on how to safely throw away a full sharps container in your specific state.
Spevigo (spesolimab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Severe infection | Long-term or recurrent infection | Other conditions that raise your risk of infection | Taking medications that weaken your immune system
Spevigo (spesolimab) can affect your body's ability to fight off infections. This can raise your risk of getting serious and sometimes life-threatening infections. For example, Spevigo (spesolimab) can raise your risk for a new tuberculosis (TB) infection or for a previous TB infection to come back.
Before you start Spevigo (spesolimab), tell your care team about the medical conditions you have. You'll need to get tested for TB before you start this medication and get treated if it's confirmed that you have TB. Also let your care team know about the medications you take because some medications can weaken your immune system further and put your at even higher risk for infection.
Get immediate medical care right away if you develop symptoms of an infection like fever, cough, difficulty breathing, weakness, sweating, chills, and confusion. You might have to stop taking Spevigo (spesolimab) so your body can fight the infection.
Risk factors: Getting Spevigo (spesolimab) as an IV infusion
Severe allergic reactions to Spevigo (spesolimab) are possible, including life-threatening reactions like facial swelling and anaphylaxis (e.g., closing of the throat). Some people have also reported developing an allergic reaction called drug reaction with eosinophilia and systemic symptoms (DRESS), which has symptoms like fever, rash, and swollen lymph nodes. Get medical help right away if you think you're experiencing an allergic reaction.
For allergic reactions during an IV infusion of Spevigo (spesolimab), your care team will pause the infusion and consider giving you medications to relieve your symptoms. Once your symptoms get better, your care team might restart the infusion at a slower speed. For more severe allergic reactions, your care team might stop treatment altogether.
Avoid getting live vaccines during your treatment with Spevigo (spesolimab) and for at least 4 months after your last dose. It's not known whether live vaccines are safe to get while you're taking Spevigo (spesolimab). Examples of live vaccines include the nasal spray version of the flu vaccine (FluMist), Varivax (chickenpox vaccine), and MMR (measles, mumps, and rubella vaccine). It's best to be up to date on all your vaccines before you start Spevigo (spesolimab). Let your prescriber or pharmacist know that you're taking Spevigo (spesolimab) before you get any vaccines.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
2 prefilled syringes of 150mg/ml | 1 carton | $18316.53 | $18316.53 |
Injection into the vein (IV)
Treatment of a GPP flare: The typical dose is 900 mg IV once for a GPP flare. The infusion is given over at least 1.5 hours. If your flare symptoms don't go away, your prescriber might give you an additional 900 mg dose of medication as an IV infusion one week after the first dose.
Injection under the skin
Maintenance treatment of GPP when you haven't had any flares: The typical dose is 600 mg injected under the skin once. Then 4 weeks later, the typical dose is 300 mg injected under the skin every 4 weeks.
Maintenance treatment after an IV infusion of Spevigo (spesolimab) for a GPP flare: Starting 4 weeks after you complete IV treatment with Spevigo (spesolimab), you can continue taking the medication as an injection under the skin using the prefilled syringes. The typical dose is 300 mg injected under the skin every 4 weeks.
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Bachelez, H., et al. (2021). Trial of spesolimab for generalized pustular psoriasis. The New England Journal of Medicine.
Boehringer Ingelheim. (2022). FDA approves the first treatment option for generalized pustular psoriasis flares in adults.
Boehringer Ingelheim. (2024). Spevigo® approved for expanded indications in China and the US.
Boehringer Ingelheim Pharmaceuticals, Inc. (2024). Instructions for use: Spevigo® (spea VEE go) (spesolimab-sbzo) injection for subcutaneous use.
Boehringer Ingelheim Pharmaceuticals, Inc. (2024). Spevigo- spesolimab-sbzo injection [package insert]. DailyMed.
MedlinePlus. (2017). Generalized pustular psoriasis.
National Organization for Rare Disorders. (2024). Generalized pustular psoriasis.
National Psoriasis Foundation. (n.d.). Generalized pustular psoriasis.
Sachen, K. L., et al. (2022). Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions. Cytokine.
U.S. Food and Drug Administration. (2021). Safely using sharps (needles and syringes) at home, at work and on travel.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.